- Stocks
- Pharma & Healthcare
- Chennai Meenaks
Chennai Meenaks share price
NSE: CMMHOSPPharma & HealthcareMedical Care Facilities
Chennai Meenaks at a glance
With a market capitalisation of ₹29 Cr, it ranks 3391st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was 0.0% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹10 Cr (+7.0% year on year) and net profit −₹0 Cr (−106.5%), on a standalone basis. Promoters held 57.10% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹29 CrRank 3391 on NSE
- Price to book
- -12.21×FY25
- EPS (TTM)
- −₹1.54to Q4 FY26
- ROE
- 0.0%FY25
- ROCE
- −5.0%FY25
- Debt to equity
- -5.63FY25
- Net profit margin
- −3.9%FY25
- Book value / share
- −₹2.53FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Chennai Meenaks quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr |
| Revenue YoY | +33.8% | +13.7% | +14.5% | −4.0% | −1.1% | +17.3% | +3.2% | +7.0% |
| Net profit | −₹0 Cr | −₹1 Cr | −₹1 Cr | ₹0 Cr | −₹1 Cr | ₹0 Cr | −₹1 Cr | −₹0 Cr |
| Net profit YoY | −2,000.0% | −1,775.0% | — | — | — | — | — | −106.5% |
| Net margin | −4.3% | −8.3% | −7.1% | 3.4% | −8.6% | 1.6% | −5.9% | −0.2% |
| EPS | −₹0.51 | −₹0.90 | −₹0.84 | ₹0.42 | −₹0.99 | ₹0.20 | −₹0.72 | −₹0.03 |
Chennai Meenaks financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹26 Cr | ₹19 Cr | ₹31 Cr | ₹29 Cr | ₹38 Cr | ₹35 Cr |
| Operating profit | ₹1 Cr | −₹1 Cr | ₹4 Cr | ₹1 Cr | ₹0 Cr | −₹1 Cr |
| Net profit | ₹1 Cr | −₹1 Cr | ₹4 Cr | ₹1 Cr | −₹0 Cr | −₹1 Cr |
| EPS (₹) | ₹0.74 | −₹1.67 | ₹5.32 | ₹1.19 | −₹0.60 | −₹1.84 |
| Cash from operations | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| Total debt | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| Shareholders' equity | −₹4 Cr | −₹5 Cr | −₹1 Cr | ₹0 Cr | −₹0 Cr | −₹2 Cr |
Chennai Meenaks shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 57.10% | 35.66% | 57.10% | 57.10% | 57.10% | 57.10% |
| Domestic institutions | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% |
| Non-institutions | 42.76% | 64.20% | 42.76% | 42.76% | 42.76% | 42.76% |
Chennai Meenaks vs peers
The listed Pharma & Healthcare companies nearest to Chennai Meenaks by market capitalisation.
Ask anything about Chennai Meenaks
Pivot answers on the live chart with evidence you can check, and tests strategies against CMMHOSP's own history. Try: “Why has CMMHOSP moved over the last three months?” · “Backtest a 50-day moving-average crossover on CMMHOSP over five years” · “Compare CMMHOSP with MEDICAPQ on margins and valuation”
Frequently asked questions about Chennai Meenaks
What is the market cap of Chennai Meenaks?
Chennai Meenaks' market capitalisation is ₹29 Cr (₹29 Cr) at the 22 Oct 2026 close, ranking 3391st among the NSE companies Pivot tracks.
What is the ROE and ROCE of Chennai Meenaks?
Return on equity was 0.0% in FY25 and return on capital employed was −5.0% in FY25 (standalone figures).
Is Chennai Meenaks a debt-free company?
Chennai Meenaks is close to debt-free: its debt-to-equity ratio was -5.63 in FY25.
What were Chennai Meenaks' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Chennai Meenaks reported revenue of ₹10 Cr, +7.0% year on year, and net profit of −₹0 Cr, −106.5% year on year.
What is the shareholding pattern of Chennai Meenaks?
As of 30 Jun 2026: promoters 57.10%, domestic institutions 0.14%, non-institutions 42.76%.
Who are Chennai Meenaks' competitors?
The listed Pharma & Healthcare companies closest to Chennai Meenaks by market cap are Medi-Caps, KK Shah Hospita, Panjon, Soni Medicare, Tejnaksh and SAMSRITA LABS.
Is Chennai Meenaks a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Chennai Meenaks' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CMMHOSP against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with C · all NSE stocks · this page as text